Introduction
============

Intensive insulin therapy has been shown to improve outcomes in critically ill patients \[[@B1]\]. We evaluated a protocol aimed at achieving a blood glucose concentration of 4--6 mmol/l \[[@B2]\] in patients in an adult cardiothoracic intensive care unit.

Methods
=======

Records of 552 consecutive patient admissions over a 6-month period were reviewed and compared with 523 patients admitted over a similar time prior to introduction of the protocol.

Results
=======

Age (median 64 years), sex and APACHE II scores (median 12) and reasons for admission were not significantly different between the groups. Use of intravenous insulin infusions increased from 57% to 87% of patients (*P*\< 0.01) and median insulin infusion rate increased from 0.4 to 1.6 units/hour (*P*\< 0.01). The mean glucose concentration decreased from 8.3 to 7.2 mmol/l (*P*\< 0.01) and the hyperglycaemic index \[[@B3]\] decreased from 2.2 to 1.1 mmol/l.

Intensive care length of stay decreased from 1.8 to 1.0 days (median, *P*\< 0.01). Intensive care mortality was not significantly different (4.2% \[post\] vs 5.2% \[pre\], *P*\> 0.05). There were no significant differences in requirements for blood transfusion, use of inotropes, haemofiltration or the number of patients with bilirubin concentration \> 32 μmol/l. The area under the curve for C-reactive protein concentrations corrected for length of stay was significantly lower in the intensive insulin protocol group (89.6 vs 62.0 mg/l, median, *P*\< 0.01).

Conclusion
==========

The mean glucose concentration was not in the target range despite a significant increase in insulin administration. In this observational study the use of an intensive insulin protocol was associated with decreased C-reactive protein concentrations and shorter intensive care unit length of stay. Tighter control of glucose concentrations may be necessary to achieve other previously described benefits of intensive insulin therapy \[[@B4]\].
